|
PF-33260 |
Garamicina solución oftalmica |
2014-07-23 |
|
Schering Plough S.A.de C.V. |
Estados Unidos de América
|
Agencias J.I. Cohen |
Amicelco |
Bodega Farmacéutica S.A. |
Colon S.A. |
Lanquetin S.A. |
Merigal S.A. |
Onco-servicios, S. A. |
Refasa S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33259 |
Garasone solución oftalmica |
2014-07-23 |
|
Schering Plough S.A.de C.V. |
Estados Unidos de América
|
Agencias J.I. Cohen |
Amicelco |
Bodega Farmacéutica S.A. |
Colon S.A. |
Lanquetin S.A. |
Merigal S.A. |
Onco-servicios, S. A. |
Refasa S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-20294 |
Primobolan depot 50 mg/mL solución inyectable |
2003-09-17 |
|
Schering Guatemalteca, S.A. |
Guatemala
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-20355 |
Primostat 200 mg/2 mL solución inyectable |
2003-09-28 |
|
Schering Guatemalteca, S.A. |
Guatemala
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-20358 |
Neogynon CD grageas |
2008-09-28 |
|
Schering Guatemalteca, S.A. |
Guatemala
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38716 |
CLARITYNE-D Solución Oral Pediátrica |
2012-04-16 |
|
Schering-Plough, S.A. De C.V. |
Mexico
|
Agencias J. I. Cohen |
Amicelco |
Bodega Farmacéutica S.A. |
Colon S.A. |
Lanquetin S.A. |
Refasa S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39260 |
BROQUIXOL Solución oral |
2017-07-31 |
|
Schering-Plough, S.A. De C.V. |
Mexico
|
Merigal |
Agencias J. I. Cohen |
Amicelco |
Bodega Farmacéutica S.A. |
Colon S.A. |
Lanquetin S.A. |
Refasa S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39607 |
CLARIXOL tabletas |
2012-10-23 |
|
Schering Plough S.A.de C.V. |
Mexico
|
Onco-Servicios, S.A. |
Refasa |
Merigal |
Bodega Farmacéutica, S.A. |
Amicelco |
Colon S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39963 |
AERIUS Solución Oral |
2018-01-08 |
|
Schering-Plough, S.A. De C.V. |
Mexico
|
Amicelco |
Agencias J.I. Cohen |
Droguería Colón |
Refasa |
Merigal |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-41968 |
TABCIN EXTRA FUERTE Tabletas |
2023-11-24 |
|
Bayer, S.A. |
Mexico
|
Bayer, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|